The future analysis of RNA-seq and ChIP-seq of the two factors compared in different subtype cells of breast cancer would provide a foundation to describe the detailed picture of FOXP2 and FOXA2 on regulating EMT progression and metastasis of breast cancer cells. The gene discussed is FOXA2; the disease is breast carcinoma.